Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cervi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry|January 28, 2006
Bicyclic carbohydrate-derived scaffolds for combinatorial librariesGiovanni Cervi, Francesco Peri, Carlo Battistini, et al.
European Journal of Medicinal Chemistry|April 11, 2024
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitorsGiovanni Cervi, Roberto D'Alessio, Simona Bindi, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinasesFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
Journal of Medicinal Chemistry|July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitorMaria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
Nature Chemical Biology|July 30, 2013
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathPaola Magnaghi, Roberto D'Alessio, Barbara Valsasina, et al.
Journal of Medicinal Chemistry|December 5, 2014
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitorsGiovanni Cervi, Paola Magnaghi, Daniela Asa, et al.
Bioorganic & Medicinal Chemistry|September 7, 2010
Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activitySimona Bindi, Daniele Fancelli, Cristina Alli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry|January 28, 2006
Bicyclic carbohydrate-derived scaffolds for combinatorial librariesGiovanni Cervi, Francesco Peri, Carlo Battistini, et al.
European Journal of Medicinal Chemistry|April 11, 2024
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitorsGiovanni Cervi, Roberto D'Alessio, Simona Bindi, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinasesFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
Journal of Medicinal Chemistry|July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitorMaria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
Nature Chemical Biology|July 30, 2013
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathPaola Magnaghi, Roberto D'Alessio, Barbara Valsasina, et al.
Journal of Medicinal Chemistry|December 5, 2014
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitorsGiovanni Cervi, Paola Magnaghi, Daniela Asa, et al.
Bioorganic & Medicinal Chemistry|September 7, 2010
Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activitySimona Bindi, Daniele Fancelli, Cristina Alli, et al.
Pageof 1